|
Sun Pharma Advanced Research Company Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
5225.45 Cr.
|
P/BV
|
-67.53
|
Book Value (Rs.)
|
-2.38
|
|
52 Week High/Low (Rs.)
|
241/109
|
FV/ML
|
1/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/09/2020
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 |
| | | | |
| PER SHARE RATIOS | | | |
| | | | |
| Basic EPS (Rs.) | -10.55 | -11.93 | -7.82 |
| Diluted EPS (Rs.) | -10.55 | -11.93 | -7.82 |
| Cash EPS (Rs.) | -10.17 | -11.55 | -6.50 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -6.68 | 3.88 | 15.80 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -6.68 | 3.88 | 15.80 |
| Revenue From Operations / Share (Rs.) | 2.21 | 2.33 | 7.36 |
| PBDIT / Share (Rs.) | -9.90 | -11.48 | -6.26 |
| PBIT / Share (Rs.) | -10.28 | -11.87 | -6.62 |
| PBT / Share (Rs.) | -10.56 | -11.92 | -6.86 |
| Net Profit / Share (Rs.) | -10.55 | -11.93 | -6.86 |
| NP After MI And SOA / Share (Rs.) | -10.55 | -11.93 | -6.86 |
| | | | |
| PROFITABILITY RATIOS | | | |
| | | | |
| PBDIT Margin (%) | -447.77 | -493.24 | -85.09 |
| PBIT Margin (%) | -465.04 | -509.80 | -90.01 |
| PBT Margin (%) | -477.63 | -512.05 | -93.21 |
| Net Profit Margin (%) | -477.25 | -512.55 | -93.21 |
| NP After MI And SOA Margin (%) | -477.25 | -512.55 | -93.21 |
| Return on Networth / Equity (%) | 0.00 | -307.91 | -43.40 |
| Return on Capital Employeed (%) | 862.23 | -154.06 | -33.00 |
| Return On Assets (%) | -102.07 | -75.18 | -26.81 |
| Long Term Debt / Equity (X) | -0.46 | 0.00 | 0.00 |
| Total Debt / Equity (X) | -1.19 | 0.37 | 0.00 |
| Asset Turnover Ratio (%) | 0.16 | 0.11 | 0.00 |
| | | | |
| LIQUIDITY RATIOS | | | |
| | | | |
| Current Ratio (X) | 0.07 | 1.02 | 2.54 |
| Quick Ratio (X) | 0.07 | 1.02 | 2.54 |
| | | | |
| COVERAGE RATIOS | | | |
| | | | |
| Interest Coverage Ratio (%) | -35.55 | -219.89 | -26.61 |
| Interest Coverage Ratio (Post Tax) (%) | -36.89 | -227.50 | -28.15 |
| | | | |
| VALUATION RATIOS | | | |
| | | | |
| Enterprise Value (Cr.) | 5059.27 | 11897.66 | 5712.17 |
| EV / Net Operating Revenue (X) | 70.50 | 157.49 | 23.92 |
| EV / EBITDA (X) | -15.74 | -31.93 | -28.11 |
| MarketCap / Net Operating Revenue (X) | 66.93 | 158.92 | 24.39 |
| Price / BV (X) | -22.14 | 95.47 | 11.36 |
| Price / Net Operating Revenue (X) | 66.93 | 158.93 | 24.39 |
| EarningsYield | -0.07 | -0.03 | -0.03 |
